¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå º¸°í¼­(2025³â)
Chronic Disease Management Global Market Report 2025
»óǰÄÚµå : 1648578
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸¸¼º Áúȯ °ü¸® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ºñ¾àÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ¸ç 2029³â¿¡´Â CAGR 21.8%·Î 249¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø±â°£ ³» ¼ºÀåÀº ȯÀÚ Á᫐ ÄÉ¾î ¸ðµ¨, Àα¸ÀÇ ³ëÈ­, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)¿¡ ´ëÇÑ ÁÖ¸ñ, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ¼¼°èÀÇ °Ç°­ °ü¸® µ¿Çâ¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼¼°è µ¿Çâ¿¡´Â ¼¼°è °Ç°­ °úÁ¦ ¹× ÆÒµ¥¹Í ´ëÀÀ, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê ¹× Á¤Ã¥ Áö¿ø, ¼ÒºñÀÚ °Ç°­ ¾Û ¹× Ç÷§Æû, »óÈ£ ¿î¿ë¼º ¹× ÀÇ·á Á¤º¸ ±³È¯, Çൿ °Ç°­¿¡ ´ëÇÑ ³ë·Â, ¿ø°Ý ÀÇ·á È®´ë µîÀÌ Æ÷ÇԵ˴ϴÙ.

¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇØ Å©°Ô °ßÀεǰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸´Â ¸¸¼º ÁúȯÀÇ ¹ßº´ À§ÇèÀÌ °¡Àå ³ôÀº 65¼¼ ÀÌ»óÀÇ ³ëÀÎÀ» ÀǹÌÇÕ´Ï´Ù. ¸¸¼º ÁúȯÀº Á¾Á¾ ÀÇ·á Ä¡·á ¹× Àå±â Áö¿ø ¼­ºñ½º¿¡ ´ëÇÑ Çʿ伺À» ³ôÀÌ°í ¸¸¼º Áúȯ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 10¿ù ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ ±¹Á¦ °øÁߺ¸°Ç ±â°üÀÎ ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¼­¿¡ µû¸£¸é 2030³â±îÁö ¼¼°è 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÇ ³ëÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ 2050³â±îÁö 60¼¼ ÀÌ»óÀÇ °í·ÉÀÚ´Â ¼¼°è¿¡¼­ 21¾ï¸íÀÌ µÈ´Ù°í ÇÕ´Ï´Ù. ±× °á°ú, ³ëÀÎ Àα¸ Áõ°¡´Â ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÏ°Ô µË´Ï´Ù.

¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¾ÕÀ¸·Î ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼º ÁúȯÀº 3°³¿ù ÀÌ»ó Áö¼ÓµÇ¸ç ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ¾ÇÈ­µÇ´Â Áúº´À» ¸»ÇÕ´Ï´Ù. ¸¸¼º ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿ø°Ý ¸ð´ÏÅ͸µ, ¸ÂÃãÇü ÀÇ·á, µ¥ÀÌÅÍ Á᫐ Á¢±Ù¹ýÀ» Æ÷ÇÔÇÑ ¾ö°ÝÇÑ °ü¸® ÇÁ·Î±×·¥ ¹× ±â¼úÀÌ °³¹ßµÇ¾î ¸¸¼º Áúȯ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ À̲ø°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù¿¡ ¹Ì±¹ ±¹¸³ÀÇÇÐ µµ¼­°ü(National Library of Medicine)ÀÌ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2050³â±îÁö 50¼¼ À̻󿡼­ Àû¾îµµ ÇϳªÀÇ ¸¸¼º ÁúȯÀ» °¡Áø »ç¶÷ÀÇ ¼ö°¡ 99.5%(1¾ï 4,266¸¸¸í) Áõ°¡ÇÑ´Ù°í ÇÕ´Ï´Ù. µû¶ó¼­ Èñ±ÍÁúȯ, ¸¸¼º Áúȯ, À¯Àü¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀÌ ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, COVID-19, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã °æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°è ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The chronic disease management refer to software and tools used to manage the symptoms of long-term conditions and delay the advancement of chronic conditions to ensure the safety of life.

The chronic disease management solutions are deployed through on-premises, cloud-based or web-based platforms. The on-premises deployment of chronic disease management solutions and services refers to software solutions and tools that are implemented in-house and as part of an organization's IT infrastructure, where the solution, as well as any connected procedures, are the responsibility of the enterprise. They are used for the management of different diseases which includes cardiovascular diseases, diabetes, cancer, asthma, and chronic obstructive pulmonary disorders. The services in chronic disease management include consulting services, implementation services, and educational services. Chronic disease management services are utilized by both providers and payers.

The chronic disease management market research report is one of a series of new reports from The Business Research Company that provides chronic disease management market statistics, including Chronic disease management industry global market size, regional shares, competitors with a chronic disease management market share, detailed chronic disease management market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management industry. This chronic disease management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic disease management market size has grown rapidly in recent years. It will grow from $9.55 billion in 2024 to $11.36 billion in 2025 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to data analytics for population health management, empowerment through patient education, value-based care models, customized treatment plans, focus on preventive healthcare.

The chronic disease management market size is expected to see exponential growth in the next few years. It will grow to $24.97 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to patient-centric care models, population aging, focus on remote patient monitoring (rpm), increasing prevalence of chronic diseases, global healthcare trends. Major trends in the forecast period include global health challenges and pandemic response, government initiatives and policy support, consumer health apps and platforms, interoperability and health information exchange, focus on behavioral health, telehealth expansion.

The growth of the chronic disease management market is being significantly driven by the increase in the geriatric population. The geriatric population is defined as individuals aged 65 and older, who are at the highest risk of developing chronic diseases. Chronic illnesses often lead to a greater need for medical care and long-term supportive services, thereby raising the demand for chronic disease management solutions. For example, in October 2024, a report from the World Health Organization (WHO), a Switzerland-based agency focused on international public health, stated that by 2030, one in six people globally is expected to be aged 60 or older. Furthermore, by 2050, there will be 2.1 billion individuals worldwide who are 60 years or older. Consequently, the increase in the geriatric population is set to drive the growth of the chronic disease management market.

The rising prevalence of chronic disorders is expected to propel the growth of the chronic disease management market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Th rise in chronic diseases has led to the development of targeted management programs and technologies, including remote monitoring, personalized medicine, and data-driven approaches, driving the demand for chronic disease management solutions. For instance, in January 2023, according to a report issued by the US-based National Library of Medicine, which is operated by the federal government, the number of people in the USA aged 50 and older who have at least one chronic condition will increase by 99. 5% (142. 66 million) by 2050. Therefore, the rising prevalence of rare, chronic, and inherited disorders is driving the growth of the chronic disease management market.

Technological advancement is a key trend gaining popularity in the chronic disease management market. Advanced technologies like artificial intelligence (AI) are being adopted to treat chronic diseases. By utilizing AI, medical personnel can witness advances in early intervention and patient outcomes for patients suffering from heart disease, cancer, and diabetes. For instance, in February 2022, Biofourmis, a Boston-based startup specializing in artificial intelligence-driven virtual care and digital pharmaceuticals, has developed Bioformis Care, a service that provides high-quality remote care to patients suffering from chronic diseases. Biofourmis Care will concentrate on increasing provider adherence to care recommendations and spotting patterns of clinical deterioration to allow for early treatments.

Major companies operating in the chronic disease management market are developing and expanding their operations through strategic partnerships. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2023, Best Buy Health, a division of Best Buy, a US-based consumer electronics retailer, partnered with Geisinger, a US-based health and wellness organization focused on making better health easier for communities through primary care, specialty medicine, and other services. Through this partnership, they will improve chronic disease management at home by combining their expertise and creating technology and services for organizations entering the chronic care management space.

In March 2022, Phablecare, an India-based chronic disease management company, acquired Fused Training for an undisclosed amount. Through this acquisition, Phablecare will expand and strengthen its Type1 diabetes verticle. Fused Training is an India-based diabetes management company that provides support to people living with diabetes.

Major companies operating in the chronic disease management market include Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health

North America was the largest region in the chronic disease management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic disease management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The chronic disease management market includes revenues earned by entities by providing illness management screenings services, check-ups, treatment monitoring and coordination, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Disease Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic disease management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chronic disease management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic disease management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chronic Disease Management Market Characteristics

3. Chronic Disease Management Market Trends And Strategies

4. Chronic Disease Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Chronic Disease Management Growth Analysis And Strategic Analysis Framework

6. Chronic Disease Management Market Segmentation

7. Chronic Disease Management Market Regional And Country Analysis

8. Asia-Pacific Chronic Disease Management Market

9. China Chronic Disease Management Market

10. India Chronic Disease Management Market

11. Japan Chronic Disease Management Market

12. Australia Chronic Disease Management Market

13. Indonesia Chronic Disease Management Market

14. South Korea Chronic Disease Management Market

15. Western Europe Chronic Disease Management Market

16. UK Chronic Disease Management Market

17. Germany Chronic Disease Management Market

18. France Chronic Disease Management Market

19. Italy Chronic Disease Management Market

20. Spain Chronic Disease Management Market

21. Eastern Europe Chronic Disease Management Market

22. Russia Chronic Disease Management Market

23. North America Chronic Disease Management Market

24. USA Chronic Disease Management Market

25. Canada Chronic Disease Management Market

26. South America Chronic Disease Management Market

27. Brazil Chronic Disease Management Market

28. Middle East Chronic Disease Management Market

29. Africa Chronic Disease Management Market

30. Chronic Disease Management Market Competitive Landscape And Company Profiles

31. Chronic Disease Management Market Other Major And Innovative Companies

32. Global Chronic Disease Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Disease Management Market

34. Recent Developments In The Chronic Disease Management Market

35. Chronic Disease Management Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â